Drug profile · INN
chlorpromazine hydrochloride
CHLORPROMAZINE HYDROCHLORIDE
chlorpromazine hydrochloride (CHLORPROMAZINE HYDROCHLORIDE) is a d2-like dopamine receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — chlorpromazine hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
chlorpromazine hydrochloride (CHLORPROMAZINE HYDROCHLORIDE) is a d2-like dopamine receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
D2-like dopamine receptor antagonist
Primary target: D2-like dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is chlorpromazine hydrochloride?
chlorpromazine hydrochloride (CHLORPROMAZINE HYDROCHLORIDE) is a d2-like dopamine receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for chlorpromazine hydrochloride?
CHLORPROMAZINE HYDROCHLORIDE is a marketed brand name for chlorpromazine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of chlorpromazine hydrochloride?
chlorpromazine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.